Skip to main content
Sarcoma logoLink to Sarcoma
. 2003 Jun;7(2):69–73. doi: 10.1080/13577140310001607293

Synovial Chondromatosis and Chondrosarcoma: A Diagnostic Dilemma

Brita L Sperling 1, Steven Angel 1, Grant Stoneham 2, Vance Chow 2, Andrew McFadden 3, Rajni Chibbar 1,
PMCID: PMC2395520  PMID: 18521371

Abstract

Purpose: The progression of synovial chondromatosis to chondrosarcoma is very rare. Distinction between these two entities may be difficult on histology alone, and should be based on clinical, radiographic and microscopic evidence. Immunohistochemical markers that would facilitate differentiation between synovial chondromatosis and chondrosarcoma are currently being investigated.

Patients: We describe the cases of two patients who presented with synovial chondromatosis and progression to synovial chondrosarcoma during periods of 7 and 11 years. Several biopsies and resected specimens demonstrated synovial chondromatosis before a diagnosis of chondrosarcoma was made.

Method: We have examined five markers (Bcl2, Ki67, p27, p16, and p53) in all specimens from these cases, as well as known cases of chondromatosis and chondrosarcoma for control purposes.

Results: We found increased expression of Bcl2 in benign chondromatosis compared to synovial or central chondrosarcomas.

Discussion: Distinction between chondromatosis and its progression to low grade chondrosarcoma is difficult at histological level, and must involve incorporation of clinical and radiographical data. Although preliminary, our study suggests that reduced or absent expression of Bcl2 is associated withmalignant transformation of chondromatosis.

Full Text

The Full Text of this article is available as a PDF (299.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertoni F., Unni K. K., Beabout J. W., Sim F. H. Chondrosarcomas of the synovium. Cancer. 1991 Jan 1;67(1):155–162. doi: 10.1002/1097-0142(19910101)67:1<155::aid-cncr2820670127>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  2. Blokx W. A., Rasing L. A., Veth R. P., Pruszczynski M. Late malignant transformation of biopsy proven benign synovial chondromatosis: an unexpected pitfall. Histopathology. 2000 Jun;36(6):564–566. doi: 10.1046/j.1365-2559.2000.00918.x. [DOI] [PubMed] [Google Scholar]
  3. Bovée J. V., van den Broek L. J., Cleton-Jansen A. M., Hogendoorn P. C. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest. 2000 Dec;80(12):1925–1934. doi: 10.1038/labinvest.3780202. [DOI] [PubMed] [Google Scholar]
  4. Davis R. I., Hamilton A., Biggart J. D. Primary synovial chondromatosis: a clinicopathologic review and assessment of malignant potential. Hum Pathol. 1998 Jul;29(7):683–688. doi: 10.1016/s0046-8177(98)90276-3. [DOI] [PubMed] [Google Scholar]
  5. Manivel J. C., Dehner L. P., Thompson R. Case report 460: Synovial chondrosarcoma of left knee. Skeletal Radiol. 1988;17(1):66–71. doi: 10.1007/BF00361459. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES